60度製薬は 2月24日に Nasdaqの価格要求を満たすために 1対5のリバース株分割を実施しました. 60 Degrees Pharmaceuticals executes 1-for-5 reverse stock split, effective Feb 24, to meet Nasdaq's price requirement.

60度製薬は 1対5の逆株分割を発表 ナスダックの最低入札価格1ドルを満たすために 60 Degrees Pharmaceuticals announced a 1-for-5 reverse stock split to meet Nasdaq's $1.00 minimum bid price requirement. 分割は2025年2月24日に発効し,すべての株主は,分割株を発行せずに,その株を5対1で統合します. The split will take effect February 24, 2025, and all stockholders will see their shares combine five-to-one without issuing fractional shares. 株式は,新CUSIP番号83006G401と"SXTP"の下で取引を続ける. The stock will continue trading under 'SXTP' with a new CUSIP number 83006G401.